Remnant Lipoproteins As Strong Key Particles to Atherogenesis
Author:
Affiliation:
1. Laboratory of Nutritional Physiology, Faculty of Nutrition, Kobegakuin University, Kobe, Japan
2. Faculty of Health Sciences, Kobe University Graduate School of Health Sciences, Kobe, Japan
Publisher
Japan Atherosclerosis Society
Subject
Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/jat/16/3/16_E598/_pdf
Reference77 articles.
1. 1) Kannel WB, Castelli WP, Gordon T, McNamara PM: Serum cholesterol, lipoproteins, and risk of coronary heart disease: The Framingham study. Ann Intern Med, 1971; 74: 1-12
2. 2) Iso H, Naito Y, Sato S, Kitamura A, Okamura T, Sankai T, Shimamoto T, Iida M, Komachi Y: Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol, 2001; 153: 490-499
3. 3) Eberly LE, Stamler J, Neaton JD, for the Multiple Risk Factor Intervention Trial Research Group: Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med, 2003; 163; 1077-1083
4. 4) Imaizumi K, Fainaru M, Havel RJ: Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins. J Lipid Res, 1978; 19: 712-722
5. 5) Cooper AD: In: Zakim D, Boyer T. editors. Hepatology: a textbook of liver disease. 2nd edn. Vol.1. Philadelphia: WB Saunders; 1989; 96-123
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial;eClinicalMedicine;2024-01
2. The value of platelet-rich plasma-derived extracellular vesicles in modern medicine;Annals of Medicine;2023-12-08
3. Sugar and Dyslipidemia: A Double-Hit, Perfect Storm;Journal of Clinical Medicine;2023-08-31
4. Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux;Journal of Clinical Medicine;2023-06-29
5. Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis;Metabolites;2023-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3